We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCLI
9451
CALL
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$605K ﹤0.01%
10,613
-2,514
-19% -$134K
BLFS icon
9452
PUT
BioLife Solutions
BLFS
$1.7B
$605K ﹤0.01%
13,600
-19,900
-59% -$701K
BUG icon
9453
CALL
Global X Cybersecurity ETF
BUG
$1.5B
$605K ﹤0.01%
21,000
+1,800
+9% +$49K
CRK icon
9454
PUT
Comstock Resources
CRK
$4B
$605K ﹤0.01%
90,700
-14,600
-14% -$84.1K
FAF icon
9455
CALL
First American
FAF
$7.47B
$605K ﹤0.01%
9,700
-3,500
-27% -$223K
HCAT icon
9456
PUT
Health Catalyst
HCAT
$130M
$605K ﹤0.01%
+10,900
New +$581K
HLI icon
9457
PUT
Houlihan Lokey
HLI
$8.86B
$605K ﹤0.01%
7,400
+1,900
+35% +$138K
LBRDA icon
9458
CALL
Liberty Broadband Class A
LBRDA
$5.1B
$605K ﹤0.01%
+3,600
New +$563K
LTCH
9459
PUT
DELISTED
Latch, Inc. Common Stock
LTCH
$605K ﹤0.01%
+49,300
New +$536K
BLCN
9460
PUT
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
$604K ﹤0.01%
12,700
-15,200
-54% -$727K
ENSG icon
9461
The Ensign Group
ENSG
$10.6B
$604K ﹤0.01%
+6,968
New +$602K
CBIO
9462
CALL
Crescent Biopharma
CBIO
$627M
$604K ﹤0.01%
2,603
+785
+43% +$200K
KFRC icon
9463
CALL
Kforce
KFRC
$1.04B
$604K ﹤0.01%
9,600
-35,400
-79% -$2.1M
SSTI icon
9464
SoundThinking
SSTI
$73.1M
$604K ﹤0.01%
+12,383
New +$475K
VERU icon
9465
Veru
VERU
$43.8M
$604K ﹤0.01%
7,490
-58,324
-89% -$5.14M
WCLD
9466
PUT
WisdomTree Cloud Computing Fund
WCLD
$332M
$604K ﹤0.01%
10,800
+5,000
+86% +$254K
ODT
9467
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$604K ﹤0.01%
172,989
-30,475
-15% -$105K
CBT icon
9468
PUT
Cabot Corp
CBT
$4.39B
$603K ﹤0.01%
10,600
-2,800
-21% -$165K
ADUS icon
9469
PUT
Addus HomeCare
ADUS
$2.2B
$602K ﹤0.01%
+6,900
New +$671K
CGBD icon
9470
Carlyle Secured Lending
CGBD
$766M
$601K ﹤0.01%
45,497
-25,108
-36% -$342K
FDMO icon
9471
Fidelity Momentum Factor ETF
FDMO
$930M
$601K ﹤0.01%
12,357
-47,004
-79% -$2.21M
HLX icon
9472
CALL
Helix Energy Solutions
HLX
$1.52B
$601K ﹤0.01%
105,200
+37,800
+56% +$199K
INDF
9473
DELISTED
Nifty India Financials ETF
INDF
$601K ﹤0.01%
+17,510
New +$577K
SCS
9474
PUT
DELISTED
Steelcase
SCS
$601K ﹤0.01%
39,800
-16,700
-30% -$241K
SCZ icon
9475
PUT
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
$601K ﹤0.01%
8,100
-19,300
-70% -$1.45M

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.